Advisor Group Holdings, Inc. T2 Biosystems, Inc. Transaction History

Advisor Group Holdings, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.09 - $565.0 $2,394 - $15 Million	26,600 Added 47.0%	83,200 $9,000
Q2 2022 Aug 10, 2022	SELL	$0.15 - $0.54 $45 - $162	-300 Reduced 0.53%	56,600 $9,000
Q1 2022 May 04, 2022	SELL	$0.36 - $0.57 $38,304 - $60,647	-106,400 Reduced 65.16%	56,900 $29,000
Q3 2021 Nov 05, 2021	SELL	$0.86 - $1.21 $108,689 - $152,923	-126,383 Reduced 43.63%	163,300 $151,000
Q2 2021 Aug 02, 2021	SELL	$1.04 - $1.69 $55,345 - $89,936	-53,217 Reduced 15.52%	289,683 $346,000
Q1 2021 May 13, 2021	SELL	$1.32 - $3.79 $972,322 - $2.79 Million	-736,608 Reduced 68.24%	342,900 $556,000
Q4 2020 Feb 10, 2021	BUY	$1.06 - $1.51 $436,834 - $622,283	412,108 Added 61.75%	1,079,508 $1.34 Million
Q3 2020 Nov 12, 2020	BUY	$1.15 - $2.1 $652,395 - $1.19 Million	567,300 Added 566.73%	667,400 $907,000
Q2 2020 Aug 14, 2020	BUY	$0.48 - $1.67 $32,304 - $112,391	67,300 Added 205.18%	100,100 $128,000
Q1 2020 May 18, 2020	BUY	$0.28 - $1.23 $9,184 - $40,344	32,800 New	32,800 $21,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $3.88M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.